Correlation Between Trevi Therapeutics and Bioatla

Can any of the company-specific risk be diversified away by investing in both Trevi Therapeutics and Bioatla at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trevi Therapeutics and Bioatla into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Trevi Therapeutics and Bioatla, you can compare the effects of market volatilities on Trevi Therapeutics and Bioatla and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trevi Therapeutics with a short position of Bioatla. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trevi Therapeutics and Bioatla.

Diversification Opportunities for Trevi Therapeutics and Bioatla

0.05

Correlation Coefficient

Trevi Therapeutics  Bioatla

Significant diversification

The 3 months correlation between Trevi and Bioatla is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and Bioatla in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bioatla and Trevi Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trevi Therapeutics are associated (or correlated) with Bioatla. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bioatla has no effect on the direction of Trevi Therapeutics i.e., Trevi Therapeutics and Bioatla go up and down completely randomly.

Pair Corralation between Trevi Therapeutics and Bioatla

Given the investment horizon of 90 days Trevi Therapeutics is expected to generate 3.39 times less return on investment than Bioatla. But when comparing it to its historical volatility, Trevi Therapeutics is 1.58 times less risky than Bioatla. It trades about 0.01 of its potential returns per unit of risk. Bioatla is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  178.00  in Bioatla on September 4, 2024 and sell it today you would lose (11.00) from holding Bioatla or give up 6.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Trevi Therapeutics  vs.  Bioatla

Trevi Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Trevi Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Trevi Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Bioatla

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Bioatla is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Trevi Therapeutics and Bioatla

The main advantage of trading using opposite Trevi Therapeutics and Bioatla positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trevi Therapeutics position performs unexpectedly, Bioatla can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will offset losses from the drop in Bioatla's long position.

The idea behind Trevi Therapeutics and Bioatla pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.